SCHEMBL15033486

SCHEMBL15033486

CCOC(=O)c1ccccc1N1C(=O)C=CC1=O

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.61
MAPT P10636 5/20 0.60
HSD17B10 Q99714 3/20 0.60
SMN1; SMN2 Q16637 3/20 0.60
GAA P10253 3/20 0.60
MAPK1 P28482 2/20 0.60
ALDH1A1 P00352 8/20 0.55
HPGD P15428 5/20 0.55
NPSR1 Q6W5P4 3/20 0.55
HSP90AA1 P07900 2/20 0.55
TDP1 Q9NUW8 2/20 0.55
HTT P42858 2/20 0.55
CACNA1B Q00975 1/20 0.55
APBA1 Q02410 1/20 0.55
TLR9 Q9NR96 2/20 0.54
PKM P14618 2/20 0.54
CCR6 P51684 2/20 0.54
ATM Q13315 1/20 0.54
MGLL Q99685 4/20 0.53
NPC1 O15118 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11357026 0.87 TDP1 (0.57) TSHRMAPTHSD17B10SMN1; SMN2GAA
SCHEMBL15023787 0.84 ALDH1A1 (0.53) TSHRMAPTHSD17B10SMN1; SMN2GAA
SCHEMBL28472385 0.82 TLR9 (0.58) TSHRHSD17B10SMN1; SMN2ALDH1A1NPSR1
SCHEMBL26098617 0.79 BCHE (0.61) TSHRMAPTHSD17B10SMN1; SMN2GAA
SCHEMBL17172445 0.78 MYC (0.71) TSHRMAPTHSD17B10SMN1; SMN2GAA
SCHEMBL2209512 0.78 TSHR (0.65) TSHRMAPTHSD17B10SMN1; SMN2GAA
Diethyl Phthalate SCHEMBL29404255 0.77 TSHR (1.00) TSHRMAPTHSD17B10MAPK1ALDH1A1
Diethyl Phthalate SCHEMBL5306972 0.77 TSHR (1.00) TSHRMAPTHSD17B10MAPK1ALDH1A1
Diethyl Phthalate SCHEMBL22296 0.77 TSHR (1.00) TSHRMAPTHSD17B10MAPK1ALDH1A1
SCHEMBL11234450 0.77 ALDH1A1 (0.47) TSHRMAPTHSD17B10SMN1; SMN2GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130156795-A1 METHODS FOR INHIBITION OF CELL PROLIFERATION, SYNERGISTIC TRANSCRIPTION MODULES AND USES THEREOF THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK 2013-06-20 US disclosed
US-20130156795-A1 METHODS FOR INHIBITION OF CELL PROLIFERATION, SYNERGISTIC TRANSCRIPTION MODULES AND USES THEREOF THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK 2013-06-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130156795-A1 METHODS FOR INHIBITION OF CELL PROLIFERATION, SYNERGISTIC TRANSCRIPTION MODULES AND USES THEREOF MKI67, DCX, CTCF TSHR 2606/4885MAPT 4158/4885HSD17B10 3597/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.